TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Johnson Fistel, Pllp
Johnson Fistel Begins Investigation on Behalf of Soleno Therapeutics, Inc. (SLNO) Shareholders Who Have Incurred Losses

Johnson Fistel is investigating potential securities law violations by Soleno Therapeutics after the company disclosed challenges with its drug VYKAT™ XR launch, following a critical report by short seller Scorpion Capital that raised concerns about the product's safety and market potential.

Insights
SLNO   negative

Stock price declined 40%, challenges emerged during product launch, potential securities law violations, and critical external report questioning drug safety and market sustainability